$2.13 Billion is the total value of Tekla Capital Management LLC's 108 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 78.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Buy | Gilead Sciences, Inc. | $265,117,000 | +112.5% | 2,490,531 | +65.5% | 12.43% | +8.5% |
| CELG | Buy | Celgene Corporation | $193,013,000 | +138.1% | 2,036,434 | +115.7% | 9.05% | +21.6% |
| VRTX | Buy | Vertex Pharmaceuticals, Inc. | $78,835,000 | +53.9% | 701,944 | +29.8% | 3.70% | -21.4% |
| ALXN | Buy | Alexion Pharmaceuticals, Inc. | $74,935,000 | +42.8% | 451,905 | +34.5% | 3.51% | -27.1% |
| AMGN | Buy | Amgen Inc. | $71,640,000 | +34.6% | 510,042 | +13.5% | 3.36% | -31.2% |
| REGN | Sell | Regeneron Pharmaceuticals, Inc. | $67,477,000 | +23.5% | 187,166 | -3.3% | 3.16% | -36.9% |
| B108PS | Buy | Actavis plcshares | $66,987,000 | +46.0% | 277,631 | +35.0% | 3.14% | -25.4% |
| BIIB | Buy | Biogen Idec, Inc. | $61,790,000 | +12.6% | 186,783 | +7.4% | 2.90% | -42.5% |
| PFE | Buy | Pfizer, Inc. | $56,249,000 | +465.8% | 1,902,241 | +467.9% | 2.64% | +188.8% |
| INCY | Buy | Incyte Corporation | $56,013,000 | +29.2% | 1,141,961 | +48.6% | 2.62% | -34.0% |
| BMRN | Buy | BioMarin Pharmaceutical Inc. | $51,272,000 | +95.6% | 710,527 | +68.6% | 2.40% | -0.1% |
| MYL | Buy | Mylan, Inc. | $45,950,000 | +36.6% | 1,010,105 | +54.9% | 2.15% | -30.2% |
| AGN | Buy | Allergan Inc. | $40,668,000 | +53.4% | 228,227 | +45.7% | 1.91% | -21.7% |
| ILMN | Buy | Illumina, Inc. | $37,594,000 | +102.8% | 229,341 | +120.9% | 1.76% | +3.5% |
| TEVA | Buy | Teva Pharmaceutical Industries Ltd.adr | $35,055,000 | +114.7% | 652,194 | +109.4% | 1.64% | +9.6% |
| JNJ | New | Johnson & Johnson | $34,878,000 | – | 327,212 | +100.0% | 1.64% | – |
| CBST | Buy | Cubist Pharmaceuticals, Inc. | $32,802,000 | +78.1% | 494,454 | +87.5% | 1.54% | -9.0% |
| TMO | Buy | Thermo Fisher Scientific Inc. | $32,479,000 | +361.3% | 266,875 | +347.3% | 1.52% | +135.6% |
| SHPG | Shire plcsponsored adr | $31,947,000 | +10.0% | 123,322 | 0.0% | 1.50% | -43.8% | |
| AET | Buy | Aetna, Inc. | $31,512,000 | +57.0% | 389,031 | +57.2% | 1.48% | -19.8% |
| JAZZ | Buy | Jazz Pharmaceuticals plcshares | $27,816,000 | +97.2% | 173,241 | +80.5% | 1.30% | +0.7% |
| ABBV | New | AbbVie Inc. | $27,795,000 | – | 481,219 | +100.0% | 1.30% | – |
| BMY | Buy | Bristol-Myers Squibb Co. | $27,394,000 | +178.7% | 535,240 | +164.2% | 1.28% | +42.4% |
| AKRXQ | Akorn, Inc. | $25,367,000 | +9.1% | 699,382 | 0.0% | 1.19% | -44.3% | |
| IPXL | Buy | Impax Laboratories, Inc. | $23,480,000 | +127.1% | 990,283 | +187.3% | 1.10% | +16.0% |
| ENDP | Buy | Endo International PLCshares | $22,977,000 | +160.0% | 336,215 | +166.4% | 1.08% | +32.8% |
| IBB | Buy | Ishares Nasdaq Biotechnology ETFetf | $21,719,000 | +29.6% | 79,375 | +21.8% | 1.02% | -33.8% |
| NBIX | Buy | Neurocrine Biosciences, Inc. | $20,088,000 | +71.2% | 1,281,950 | +62.2% | 0.94% | -12.5% |
| ALKS | Buy | Alkermes plcshares | $18,733,000 | +45.4% | 436,970 | +70.7% | 0.88% | -25.7% |
| CTRX | Buy | Catamaran Corporation | $18,276,000 | +79.2% | 433,600 | +87.7% | 0.86% | -8.4% |
| CELG | New | Celgene Corporationcall | $17,136,000 | – | 180,800 | +100.0% | 0.80% | – |
| GILD | New | Gilead Sciences, Inc.call | $17,128,000 | – | 160,900 | +100.0% | 0.80% | – |
| GEVA | New | Synageva BioPharma Corp. | $15,339,000 | – | 223,020 | +100.0% | 0.72% | – |
| MOH | Buy | Molina Healthcare, Inc. | $14,716,000 | +55.1% | 347,901 | +63.7% | 0.69% | -20.8% |
| MCK | McKesson Corporation | $13,211,000 | +4.5% | 67,862 | 0.0% | 0.62% | -46.6% | |
| SGNT | Sagent Pharmaceuticals, Inc. | $12,587,000 | +20.3% | 404,731 | 0.0% | 0.59% | -38.6% | |
| LLY | New | Eli Lilly & Co | $12,122,000 | – | 186,918 | +100.0% | 0.57% | – |
| MNTA | Buy | Momenta Pharmaceuticals, Inc. | $12,106,000 | +183.5% | 1,067,575 | +202.0% | 0.57% | +44.6% |
| ALR | Buy | Alere, Inc. | $11,553,000 | +7.8% | 297,901 | +4.0% | 0.54% | -44.9% |
| HCNPRI | New | Health Care REIT Inc. | $11,436,000 | – | 200,000 | +100.0% | 0.54% | – |
| CI | New | Cigna Corp | $11,087,000 | – | 122,251 | +100.0% | 0.52% | – |
| IRWD | Ironwood Pharmaceuticals, Inc. | $9,950,000 | -15.5% | 768,050 | 0.0% | 0.47% | -56.9% | |
| VSTM | Buy | Verastem, Inc. | $9,797,000 | +17.7% | 1,149,827 | +25.1% | 0.46% | -39.9% |
| CLDN | Celladon Corporation | $9,644,000 | -27.0% | 970,495 | 0.0% | 0.45% | -62.7% | |
| PRGO | Perrigo Company plcshares | $9,455,000 | +3.0% | 62,952 | 0.0% | 0.44% | -47.4% | |
| ACOR | Buy | Acorda Therapeutics, Inc. | $9,255,000 | +21.6% | 273,162 | +21.0% | 0.43% | -37.8% |
| DOC | New | Physicians Realty Trust | $9,216,000 | – | 671,702 | +100.0% | 0.43% | – |
| INFI | Infinity Pharmaceuticals, Inc. | $9,136,000 | +5.3% | 680,746 | 0.0% | 0.43% | -46.2% | |
| LTC | New | LTC Properties Inc. | $8,729,000 | – | 236,618 | +100.0% | 0.41% | – |
| OHI | New | Omega Healthcare Investors Inc. | $8,637,000 | – | 252,616 | +100.0% | 0.40% | – |
| SNH | New | Senior Housing Properties Trustshares | $8,567,000 | – | 409,504 | +100.0% | 0.40% | – |
| BDSI | BioDelivery Sciences International, Inc. | $8,572,000 | +41.6% | 501,553 | 0.0% | 0.40% | -27.7% | |
| CYH | New | Community Health Systems, Inc. | $8,474,000 | – | 154,672 | +100.0% | 0.40% | – |
| VTR | New | Ventas Inc. | $8,449,000 | – | 136,382 | +100.0% | 0.40% | – |
| SBRA | New | Sabra Health Care REIT Inc. | $8,351,000 | – | 343,390 | +100.0% | 0.39% | – |
| HCA | New | HCA Holdings, Inc. | $8,158,000 | – | 115,688 | +100.0% | 0.38% | – |
| SGMO | Buy | Sangamo BioSciences, Inc. | $8,090,000 | +339.9% | 750,100 | +523.0% | 0.38% | +124.3% |
| ZBH | New | Zimmer Holdings, Inc. | $8,024,000 | – | 79,800 | +100.0% | 0.38% | – |
| SYK | New | Stryker Corporation | $7,739,000 | – | 95,840 | +100.0% | 0.36% | – |
| MPW | New | Medical Properties Trust Inc. | $7,690,000 | – | 627,274 | +100.0% | 0.36% | – |
| IPXL | New | Impax Laboratories, Inc.call | $7,649,000 | – | 322,600 | +100.0% | 0.36% | – |
| STJ | New | St Jude Medical, Inc. | $7,367,000 | – | 122,510 | +100.0% | 0.34% | – |
| SRPT | New | Sarepta Therapeutics Inc.call | $7,288,000 | – | 345,400 | +100.0% | 0.34% | – |
| SRPT | New | Sarepta Therapeutics Inc. | $7,288,000 | – | 345,400 | +100.0% | 0.34% | – |
| HRTX | Heron Therapeutics, Inc. | $7,280,000 | -32.4% | 873,940 | 0.0% | 0.34% | -65.5% | |
| PKI | PerkinElmer, Inc. | $7,216,000 | -6.9% | 165,495 | 0.0% | 0.34% | -52.5% | |
| UNH | UnitedHealth Group, Inc. | $7,175,000 | +5.5% | 83,186 | 0.0% | 0.34% | -46.2% | |
| IDXX | IDEXX Laboratories, Inc. | $6,630,000 | -11.8% | 56,265 | 0.0% | 0.31% | -54.9% | |
| CLDX | New | Celldex Therapeutics, Inc.call | $6,589,000 | – | 508,400 | +100.0% | 0.31% | – |
| CLDX | New | Celldex Therapeutics, Inc. | $6,589,000 | – | 508,400 | +100.0% | 0.31% | – |
| P103PS | Buy | NPS Pharmaceuticals, Inc. | $6,211,000 | +126.7% | 238,900 | +188.2% | 0.29% | +15.9% |
| BLUE | Buy | bluebird Bio, Inc. | $6,205,000 | +195.1% | 172,927 | +217.1% | 0.29% | +50.8% |
| AMRN | Buy | Amarin Corporation plcsponsored adr | $6,151,000 | +247.7% | 5,643,412 | +461.5% | 0.29% | +77.8% |
| ELGX | New | Endologix Inc. | $5,841,000 | – | 551,000 | +100.0% | 0.27% | – |
| New | Corsicanto Ltd.note 3.5% 1/15/32 | $5,786,000 | – | 8,700,000 | +100.0% | 0.27% | – | |
| WCG | New | WellCare Health Plans Inc. | $5,349,000 | – | 88,652 | +100.0% | 0.25% | – |
| ARAY | Accuray, Inc. | $5,314,000 | -17.5% | 731,943 | 0.0% | 0.25% | -57.9% | |
| MACK | Merrimack Pharmaceuticals, Inc. | $4,985,000 | +20.4% | 567,787 | 0.0% | 0.23% | -38.4% | |
| CNC | Centene Corporation | $4,963,000 | +9.4% | 60,000 | 0.0% | 0.23% | -44.0% | |
| ALNY | Alnylam Pharmaceuticals, Inc. | $4,811,000 | +23.6% | 61,595 | 0.0% | 0.23% | -36.7% | |
| CLVS | Buy | Clovis Oncology, Inc. | $4,720,000 | +140.7% | 104,051 | +119.7% | 0.22% | +22.8% |
| INCY | New | Incyte Corporationcall | $4,586,000 | – | 93,500 | +100.0% | 0.22% | – |
| ALXN | New | Alexion Pharmaceuticals, Inc.call | $4,444,000 | – | 26,800 | +100.0% | 0.21% | – |
| NBIX | New | Neurocrine Biosciences, Inc.call | $4,413,000 | – | 281,600 | +100.0% | 0.21% | – |
| MYGN | New | Myriad Genetics, Inc.call | $4,328,000 | – | 112,200 | +100.0% | 0.20% | – |
| MYGN | New | Myriad Genetics, Inc. | $4,328,000 | – | 112,200 | +100.0% | 0.20% | – |
| BLUE | New | bluebird Bio, Inc.call | $4,248,000 | – | 118,400 | +100.0% | 0.20% | – |
| BIIB | New | Biogen Idec, Inc.call | $4,234,000 | – | 12,800 | +100.0% | 0.20% | – |
| IPCI | IntelliPharmaceutics International Inc. | $4,226,000 | -21.0% | 1,404,000 | 0.0% | 0.20% | -59.7% | |
| P103PS | New | NPS Pharmaceuticals, Inc.call | $4,056,000 | – | 156,000 | +100.0% | 0.19% | – |
| NKTR | New | Nektar Therapeuticscall | $4,041,000 | – | 334,800 | +100.0% | 0.19% | – |
| NKTR | New | Nektar Therapeutics | $4,041,000 | – | 334,800 | +100.0% | 0.19% | – |
| ILMN | New | Illumina, Inc.call | $3,869,000 | – | 23,600 | +100.0% | 0.18% | – |
| EPZM | Buy | Epizyme, Inc. | $3,830,000 | +75.4% | 141,262 | +101.3% | 0.18% | -10.0% |
| TEVA | New | Teva Pharmaceutical Industries Ltd.call | $3,687,000 | – | 68,600 | +100.0% | 0.17% | – |
| KYTH | Buy | KYTHERA Biopharmaceuticals Inc. | $3,651,000 | +94.2% | 111,433 | +127.4% | 0.17% | -1.2% |
| ALGN | New | Align Technology, Inc. | $3,638,000 | – | 70,400 | +100.0% | 0.17% | – |
| KPTI | New | Karyopharm Therapeutics Inc. | $3,563,000 | – | 101,966 | +100.0% | 0.17% | – |
| PTCT | PTC Therapeutics, Inc. | $3,483,000 | +68.3% | 79,150 | 0.0% | 0.16% | -14.2% | |
| LGND | New | Ligand Pharmaceuticals Inc. | $3,252,000 | – | 69,200 | +100.0% | 0.15% | – |
| THOR | New | Thoratec Corporation | $3,029,000 | – | 113,300 | +100.0% | 0.14% | – |
| Merrimack Pharmaceuticals, Inc.note 4.50% 7/15/20 | $2,308,000 | +17.4% | 1,485,000 | 0.0% | 0.11% | -40.0% | ||
| AGIO | New | Agios Pharmaceuticals, Inc. | $2,147,000 | – | 35,000 | +100.0% | 0.10% | – |
| MEIP | MEI Pharma, Inc. | $1,683,000 | +8.9% | 243,920 | 0.0% | 0.08% | -44.4% | |
| ACOR | New | Acorda Therapeutics, Inc.call | $1,606,000 | – | 47,400 | +100.0% | 0.08% | – |
| MGNX | Macrogenics, Inc. | $666,000 | -3.8% | 31,857 | 0.0% | 0.03% | -51.6% | |
| OGXI | OncoGenex Pharmaceuticals, Inc. | $302,000 | -28.4% | 113,100 | 0.0% | 0.01% | -64.1% | |
| SAGE | New | Sage Therapeutics, Inc. | $158,000 | – | 5,000 | +100.0% | 0.01% | – |
| AEGR | Exit | Aegerion Pharmaceuticals, Inc. | $0 | – | -20 | -100.0% | 0.00% | – |
| Exit | InterMune, Inc.note 2.5% 9/15/18 | $0 | – | -1,800,000 | -100.0% | -0.25% | – | |
| FRX | Exit | Forest Laboratories, Inc. | $0 | – | -109,875 | -100.0% | -1.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 41 | Q2 2023 | 12.4% |
| Amgen, Inc. | 41 | Q2 2023 | 5.8% |
| Biogen Inc. | 41 | Q2 2023 | 6.5% |
| Vertex Pharmaceuticals Incorporated | 41 | Q2 2023 | 5.3% |
| Regeneron Pharmaceuticals, Inc. | 41 | Q2 2023 | 9.1% |
| Illumina, Inc. | 41 | Q2 2023 | 3.4% |
| BioMarin Pharmaceutical Inc. | 41 | Q2 2023 | 2.9% |
| Teva Pharmaceutical Industries Ltd. | 41 | Q2 2023 | 3.2% |
| Neurocrine Biosciences, Inc. | 41 | Q2 2023 | 1.4% |
| McKesson Corporation | 41 | Q2 2023 | 2.2% |
View Tekla Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Rallybio Corp | January 23, 2023 | 1,727,067 | 4.6% |
| Zyla Life SciencesSold out | January 29, 2021 | 0 | 0.0% |
| ARCA biopharma, Inc. | January 24, 2020 | 36,068 | 2.3% |
| Verona Pharma plc | February 12, 2019 | 5,296,845 | 4.9% |
| Alliqua BioMedical, Inc. | February 12, 2018 | 165,000 | 3.3% |
| PIERIS PHARMACEUTICALS, INC. | February 12, 2018 | 1,962,380 | 4.4% |
| Intellipharmaceutics International Inc. | February 13, 2015 | 2,184,000 | 9.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 20,598,613 | 4.2% |
| MEDWAVE INC | February 14, 2012 | 1,277,372 | 9.8% |
| MZT Holdings, Inc. | February 14, 2012 | 2,553,420 | 4.0% |
View Tekla Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| SC 13G/A | 2023-01-23 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-01-21 |
| 13F-HR | 2021-11-12 |
View Tekla Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.